IL325890A - Modulators of the adenosine a2a and a2b receptor - Google Patents
Modulators of the adenosine a2a and a2b receptorInfo
- Publication number
- IL325890A IL325890A IL325890A IL32589026A IL325890A IL 325890 A IL325890 A IL 325890A IL 325890 A IL325890 A IL 325890A IL 32589026 A IL32589026 A IL 32589026A IL 325890 A IL325890 A IL 325890A
- Authority
- IL
- Israel
- Prior art keywords
- adenosine
- modulators
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PL2023/050060 WO2025018901A1 (en) | 2023-07-17 | 2023-07-17 | Modulators of the adenosine a2a and a2b receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325890A true IL325890A (en) | 2026-03-01 |
Family
ID=87696037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325890A IL325890A (en) | 2023-07-17 | 2023-07-17 | Modulators of the adenosine a2a and a2b receptor |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN121532395A (en) |
| AU (1) | AU2023454063A1 (en) |
| IL (1) | IL325890A (en) |
| WO (1) | WO2025018901A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058241A2 (en) | 2000-02-10 | 2001-08-16 | New York University | Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| JP2005123160A (en) | 2003-09-22 | 2005-05-12 | Nissan Motor Co Ltd | Fuel cell separator, fuel cell stack, fuel cell separator manufacturing method, and fuel cell vehicle |
| CN101060841A (en) | 2004-06-17 | 2007-10-24 | 加利福尼亚大学董事会 | Antagonizing an adenosine A2A receptor to amelioriate one or more components of addictive behavior |
| WO2017098421A1 (en) | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
| US20200369665A1 (en) | 2017-06-30 | 2020-11-26 | Ryvu Therapeutics S.A. | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor |
| WO2020128036A1 (en) | 2018-12-21 | 2020-06-25 | Ryvu Therapeutics S.A. | Modulators of the adenosine a2a receptor |
-
2023
- 2023-07-17 IL IL325890A patent/IL325890A/en unknown
- 2023-07-17 AU AU2023454063A patent/AU2023454063A1/en active Pending
- 2023-07-17 WO PCT/PL2023/050060 patent/WO2025018901A1/en not_active Ceased
- 2023-07-17 CN CN202380100439.9A patent/CN121532395A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023454063A1 (en) | 2026-01-15 |
| WO2025018901A1 (en) | 2025-01-23 |
| CN121532395A (en) | 2026-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2609879B (en) | Antagonists of the adenosine A2a receptor | |
| AU2022246176A1 (en) | Adenosine deaminase variants and uses thereof | |
| IL276873A (en) | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors | |
| IL270909A (en) | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor | |
| IL277160A (en) | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| EP4141007A4 (en) | Antiviral application of nucleoside analog or combination formulation containing nucleoside analog | |
| IL279562A (en) | Nucleosides and nucleotides with 3ʹ-hydroxy blocking groups | |
| EP4185296A4 (en) | Adenosine a2a and a2b receptor dual antagonists for immuno-oncology | |
| ZA200703229B (en) | Use of A2A adenosine receptor agonists | |
| HUE066718T2 (en) | Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors | |
| EP4040965A4 (en) | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| GB202217705D0 (en) | Multi-seat escape system and ejection seat sequencer | |
| IL311972A (en) | Activatable cytokine constructs and combination methods | |
| CA3295477A1 (en) | Modulators of the adenosine a2a and a2b receptor | |
| EP4234566A4 (en) | Modified nucleoside or nucleotide | |
| EP4192916A4 (en) | Combination therapy with adenosine receptor antagonists | |
| IL307967A (en) | Purine nucleosides, their intermediates, and methods of preparation thereof | |
| PL3833756T3 (en) | Epimerase enzymes and their use | |
| HK40081026A (en) | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | |
| HK40089682A (en) | Antagonists of the adenosine a2a receptor | |
| EP4108670A4 (en) | Bridged nucleoside and nucleotide using same | |
| HK40065313A (en) | Adenosine a2a receptor antagonists and uses thereof | |
| HK40106784A (en) | Adenosine deaminase variants and uses thereof | |
| IL287417A (en) | Cytidine derivatives and methods of forming cytidine derivatives | |
| HK40045143A (en) | Expansion of tumor infiltrating lymphocytes (tils) with adenosine a2a receptor antagonists and therapeutic combinations of tils and adenosine a2a receptor antagonists |